Interested in Joining a Registry?
Already an NCDR Participant?
The ACC’s NCDR offers seven hospital-based registries:
The Chest Pain - MI Registry™ is a risk-adjusted outcomes-based quality improvement that focuses on the processes of care for high-risk STEMI/NSTEMI patients and those with unstable angina or low-risk chest pain. The registry helps hospitals apply ACC clinical guideline recommendations in their facilities and provides invaluable tools to ensure care and achieve quality improvement goals. In addition, with the development of the COVID-19 pandemic in spring 2020, data collection in the Chest Pain – MI Registry can be augmented to include COVID-19 information to help inform this global conversation.
The AFib Ablation Registry™ assesses the prevalence, demographics, acute management and outcomes of patients undergoing atrial fibrillation (AFib) catheter ablation procedures. Its data will support the development of evidence-based guidelines for AFib treatments that will improve outcomes for patients.
The CathPCI Registry® assesses the characteristics, treatments and outcomes of cardiac disease patients who receive diagnostic catheterization and/or percutaneous coronary intervention (PCI) procedures. This powerful tool captures the data that measure adherence to ACC/AHA clinical practice guideline recommendations, procedure performance standards and appropriate use criteria for coronary revascularization. In addition, with the development of the COVID-19 pandemic in spring 2020, data collection in the Cath PCI Registry can be augmented to include COVID-19 information to help inform this global conversation.
The EP Device Implant Registry™ establishes a national standard for understanding patient characteristics, treatments, outcomes, device safety and the overall quality of care for ICD/CRT-D and select novel pacemaker procedures. Participating in the registry is still the most reliable way to ensure a hospital’s documentation meets current compliance requirements for the CMS National Coverage Determination for ICD/CRT-D primary prevention device implants.
The IMPACT Registry® assesses the prevalence, demographics, management and outcomes of pediatric and adult congenital heart disease (CHD) patients who undergo diagnostic catheterizations and catheter-based interventions. Its data support the development of evidence-based guidelines for CHD treatment that will improve outcomes for CHD patients of all ages.
The LAAO Registry™ captures data on left atrial appendage occlusion (LAAO) procedures to assess real-world procedural outcomes, short and long-term safety, comparative effectiveness and cost effectiveness. LAAO provides a treatment option to manage stroke risk for non-valvular atrial fibrillation patients who are unable to maintain adequate anticoagulation through medication therapy. The LAAO Registry is approved by the Centers for Medicare and Medicaid Services (CMS) to meet the registry requirements outlined in the national coverage decisions for Percutaneous Left Atrial Appendage Closure.
The STS/ACC TVT Registry™, created by a collaboration between the Society for Thoracic Surgeons and the ACC, monitors patient safety and real-world outcomes related to transcatheter valve replacement and repair procedures – emerging treatments for valve disease patients. Employing state-of-the-art heart valve technology, transcatheter heart valve procedures provide new treatment options for patients who are not eligible for conventional heart valve replacement or repair surgery. Learn more about the TVT Registry.